UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 48

Sortiert nach

Spray-Dried PulmoSphere™ Formulations for Inhalation Comprising Crystalline Drug Particles

AAPS PharmSciTech, 2019-02, Vol.20 (3), p.103-103, Article 103

2019

Link zum Volltext

Verfügbarkeit prüfen

Optimizing Spray-Dried Porous Particles for High Dose Delivery with a Portable Dry Powder Inhaler

Pharmaceutics, 2021-09, Vol.13 (9), p.1528

2021

Link zum Volltext

Verfügbarkeit prüfen

Design of dry powder inhalers to improve patient outcomes: it's not just about the device

Expert opinion on drug delivery, 2024-03, Vol.21 (3), p.365-380

Weers, Jeffry G

2024

Link zum Volltext

Verfügbarkeit prüfen

Targeting of Inhaled Therapeutics to the Small Airways: Nanoleucine Carrier Formulations

Pharmaceutics, 2021-11, Vol.13 (11), p.1855

2021

Link zum Volltext

Verfügbarkeit prüfen

The Confusing World of Dry Powder Inhalers: It Is All About Inspiratory Pressures, Not Inspiratory Flow Rates

Journal of aerosol medicine and pulmonary drug delivery, 2020-02, Vol.33 (1), p.1

2020

Link zum Volltext

Verfügbarkeit prüfen

Formulation Design of Dry Powders for Inhalation

Journal of pharmaceutical sciences, 2015-10, Vol.104 (10), p.3259-3288

2015

Link zum Volltext

Verfügbarkeit prüfen

Inhalation of a Dry Powder Tobramycin PulmoSphere Formulation in Healthy Volunteers

Chest, 2003-07, Vol.124 (1), p.360-366

2003

Link zum Volltext

Verfügbarkeit prüfen

Post-inhalation cough with therapeutic aerosols: Formulation considerations

Advanced drug delivery reviews, 2020, Vol.165-166, p.127-141

2020

Link zum Volltext

Verfügbarkeit prüfen

Ciprofloxacin Dry Powder for Inhalation (ciprofloxacin DPI): Technical design and features of an efficient drug–device combination

Pulmonary pharmacology & therapeutics, 2018-06, Vol.50, p.72-79

2018

Link zum Volltext

Verfügbarkeit prüfen

Enhanced design of inhaled therapeutics: what does the future hold?

Therapeutic delivery, 2016-03, Vol.7 (3), p.145-148

Weers, Jeffry G

2016

Link zum Volltext

Verfügbarkeit prüfen

Design of spray dried insulin microparticles to bypass deposition in the extrathoracic region and maximize total lung dose

International journal of pharmaceutics, 2016-09, Vol.511 (2), p.1070-1079

2016

Link zum Volltext

Verfügbarkeit prüfen

Physical Characterization of Tobramycin Inhalation Powder: I. Rational Design of a Stable Engineered-Particle Formulation for Delivery to the Lungs

Molecular pharmaceutics, 2015-08, Vol.12 (8), p.2582-2593

2015

Link zum Volltext

Verfügbarkeit prüfen

Physical Characterization of Tobramycin Inhalation Powder: II. State Diagram of an Amorphous Engineered Particle Formulation

Molecular pharmaceutics, 2017-06, Vol.14 (6), p.1950-1960

2017

Link zum Volltext

Verfügbarkeit prüfen

Idealhalers Versus Realhalers: Is It Possible to Bypass Deposition in the Upper Respiratory Tract?

Journal of aerosol medicine and pulmonary drug delivery, 2019-04, Vol.32 (2), p.55

2019

Link zum Volltext

Verfügbarkeit prüfen

In Vitro Assessment of Dose Delivery Performance of Dry Powders for Inhalation

Aerosol science and technology, 2014-10, Vol.48 (10), p.1099-1110

2014

Link zum Volltext

Verfügbarkeit prüfen

In Vitro-In Vivo Correlations Observed With Indacaterol-Based Formulations Delivered with the Breezhaler

Journal of aerosol medicine and pulmonary drug delivery, 2015-08, Vol.28 (4), p.268

2015

Link zum Volltext

Verfügbarkeit prüfen

Pulmonary formulations: what remains to be done?

Journal of aerosol medicine and pulmonary drug delivery, 2010-12, Vol.23 Suppl 2, p.S5

2010

Link zum Volltext

Verfügbarkeit prüfen

Design of fine particles for pulmonary drug delivery

Expert opinion on drug delivery, 2007-05, Vol.4 (3), p.297-313

2007

Link zum Volltext

Verfügbarkeit prüfen

Inhaler devices: what remains to be done?

Journal of aerosol medicine and pulmonary drug delivery, 2010-12, Vol.23 Suppl 2, p.S25

2010

Link zum Volltext

Verfügbarkeit prüfen

Effect of the intramolecular charge separation distance on the solution properties of betaines and sulfobetaines

Langmuir, 1991-05, Vol.7 (5), p.854-867

1991

Link zum Volltext

Verfügbarkeit prüfen

A Fourier transform infrared spectroscopic study of dodecyltrimethylammonium chloride/sodium dodecyl sulfate surfactant mixtures

Langmuir, 1990-03, Vol.6 (3), p.665-671

1990

Link zum Volltext

Verfügbarkeit prüfen

Erratum to: Scope and relevance of a pulmonary biopharmaceutical classification system AAPS/FDA/USP Workshop March 16-17th, 2015 in Baltimore, MD

AAPS open, 2016-05, Vol.2 (1), p.1-1, Article 4

2016

Link zum Volltext

Verfügbarkeit prüfen

Scope and relevance of a pulmonary biopharmaceutical classification system AAPS/FDA/USP Workshop March 16-17th, 2015 in Baltimore, MD

AAPS open, 2016-01, Vol.2 (1), p.1-20, Article 1

2016

Link zum Volltext

Verfügbarkeit prüfen

Sedimentation Field-Flow Fractionation Studies of Composition Ripening in Emulsion Mixtures

Langmuir, 1996-04, Vol.12 (7), p.1923-1925

1996

Link zum Volltext

Verfügbarkeit prüfen

Characterization of Fluorocarbon-in-Water Emulsions With Added Triglyceride

Langmuir, 2004-08, Vol.20 (18), p.7430-7435

2004

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 48

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(44)
Mit Volltextzugriff
(43)

Publikationsform

Artikel
(48)

Sprache

Englisch
(48)
Japanisch
(8)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Spray-Dried PulmoSphere™ Formulations for Inhalation Comprising Crystalline Drug Particles

Optimizing Spray-Dried Porous Particles for High Dose Delivery with a Portable Dry Powder Inhaler

Design of dry powder inhalers to improve patient outcomes: it's not just about the device

Targeting of Inhaled Therapeutics to the Small Airways: Nanoleucine Carrier Formulations

The Confusing World of Dry Powder Inhalers: It Is All About Inspiratory Pressures, Not Inspiratory Flow Rates

Formulation Design of Dry Powders for Inhalation

Inhalation of a Dry Powder Tobramycin PulmoSphere Formulation in Healthy Volunteers

Post-inhalation cough with therapeutic aerosols: Formulation considerations

Ciprofloxacin Dry Powder for Inhalation (ciprofloxacin DPI): Technical design and features of an efficient drug–device combination

Enhanced design of inhaled therapeutics: what does the future hold?

Design of spray dried insulin microparticles to bypass deposition in the extrathoracic region and maximize total lung dose

Physical Characterization of Tobramycin Inhalation Powder: I. Rational Design of a Stable Engineered-Particle Formulation for Delivery to the Lungs

Physical Characterization of Tobramycin Inhalation Powder: II. State Diagram of an Amorphous Engineered Particle Formulation

Idealhalers Versus Realhalers: Is It Possible to Bypass Deposition in the Upper Respiratory Tract?

In Vitro Assessment of Dose Delivery Performance of Dry Powders for Inhalation

In Vitro-In Vivo Correlations Observed With Indacaterol-Based Formulations Delivered with the Breezhaler

Pulmonary formulations: what remains to be done?

Design of fine particles for pulmonary drug delivery

Inhaler devices: what remains to be done?

Effect of the intramolecular charge separation distance on the solution properties of betaines and sulfobetaines

A Fourier transform infrared spectroscopic study of dodecyltrimethylammonium chloride/sodium dodecyl sulfate surfactant mixtures

Erratum to: Scope and relevance of a pulmonary biopharmaceutical classification system AAPS/FDA/USP Workshop March 16-17th, 2015 in Baltimore, MD

Scope and relevance of a pulmonary biopharmaceutical classification system AAPS/FDA/USP Workshop March 16-17th, 2015 in Baltimore, MD

Sedimentation Field-Flow Fractionation Studies of Composition Ripening in Emulsion Mixtures

Characterization of Fluorocarbon-in-Water Emulsions With Added Triglyceride

Suchergebnisse filtern